Gastroretentive Drug Delivery Systems Outsourcing Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead
Discover trends, market shifts, and competitive outlooks for the gastroretentive drug delivery systems outsourcing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Is the Current and Projected Market Size of the Gastroretentive Drug Delivery Systems Outsourcing Market Through 2034?
The market for outsourcing gastroretentive drug delivery systems has witnessed robust growth recently. The market size is set to expand from $1.39 billion in 2024 to $1.5 billion in 2025, registering a compound annual growth rate (CAGR) of 8.3%. The significant growth in the historical period is due to multiple factors such as the increasing cases of stomach and small intestine diseases, growth in drug delivery systems, a surge in gastric cancer prevalence, an escalation in government initiatives, and a rise in the number of hospitals.
In the coming years, substantial growth is projected for the gastroretentive drug delivery systems outsourcing market. It is predicted to ascend to $2.03 billion in 2029, with a compound annual growth rate (CAGR) of 7.9%. The expected growth within the forecasting period can be attributed to several elements including the rise in the number of ambulatory centers, an emphasis on patient convenience and compliance, an increasing prevalence of chronic diseases, the expansion of personalized medicine, and an aging population. Trends anticipated in the forecast period encompass advancements in multiple areas such as polymer science, formulation technologies, bioadhesive systems, novel polymers, drug release modifiers, the creation of gastroretentive dosage forms, the incorporation of digital health technologies, intelligent gastroretentive systems, and targeted drug delivery.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp
What External and Internal Drivers Are Contributing to the Growth of the Gastroretentive Drug Delivery Systems Outsourcing Market?
The increasing incidence of gastrointestinal diseases is anticipated to propel the expansion of the outsourcing market for gastroretentive drug delivery systems. This term encompasses a variety of ailments that affect the digestive system, including the stomach, liver, gallbladder, intestines, and pancreas. The upsurge in gastrointestinal diseases is due to factors such as an aging population, the use of antibiotics, infectious agents, alterations in diet, stress, lifestyle changes, and obesity. Outsourcing of gastroretentive drug delivery systems equips pharmaceutical firms with the necessary resources and expertise to tackle the growing issue of gastrointestinal disorders, thereby enhancing patient results and quality of life. For example, the US-based health organization American Cancer Society (ACS), committed to cancer elimination, recorded a 3.18% increase in gastrointestinal cancers, rising to 348,840 in January 2023 from 338,090 in 2021 in the United States. Thus, the upsurge in gastrointestinal disorders is fuelling the growth of the gastroretentive drug delivery systems outsourcing market.
Which Key Market Segments Comprise the Gastroretentive Drug Delivery Systems Outsourcing Market and Drive Its Revenue Growth?
The gastroretentive drug delivery systems outsourcing market covered in this report is segmented –
1) By Type: Floating Systems, Bioadhesive Systems, Other Types
2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms
3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications
4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users
Subsegments:
1) Floating Systems: Single Unit Systems, Multiple Unit Systems
2) Bioadhesive Systems: Hydrogels, Mucoadhesive Polymers
3) Other Types: Magnetically Assisted Systems, High-Density Systems, Osmotic Systems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15813&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Gastroretentive Drug Delivery Systems Outsourcing Market?
North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Key Market Trends in the Gastroretentive Drug Delivery Systems Outsourcing Market Over the Coming Years?
Prominent businesses in the gastroretentive drug delivery systems outsourcing market are concentrating their efforts on developing unique products like ready-to-fill (RTF) colon functional capsules. These aim to improve drug delivery effectiveness and patient comfort. The RTF colon functional capsules are essentially pre-fabricated empty capsules designed for filling with specific colon-targeted formulations or active ingredients. For example, in September 2024, German advanced drug delivery leader, Evonik, unveiled the EUDRACAP colon functional capsules for targeted oral drug delivery to the ileo-colonic region. These innovative capsules, which are the first RTF options on the market, focus on delivering sensitive active ingredients like live biotherapeutic products (LBPs). The company currently offers a technical grade, with GMP-grade variant under development. The introduction of the EUDRACAP colon is a significant breakthrough in gastroretentive drug delivery systems as it streamlines the formulation procedure and accelerates the market launch time for oral drugs.
View the full report here:
How Is the Gastroretentive Drug Delivery Systems Outsourcing Market Conceptually Defined?
Gastroretentive drug delivery systems outsourcing refers to the practice of pharmaceutical companies contracting with external service providers or contract research organizations (CROs) to develop and manufacture drug delivery systems designed to prolong the residence time of medications within the gastrointestinal (GI) tract. These systems are engineered to enhance drug absorption, improve therapeutic efficacy, and optimize patient outcomes.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15813
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
